📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adalimumab in Psoriasis: How Much Is Enough? (2019)

First Author: Billi AC

Attributed to: MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2018.08.012

PubMed Identifier: 30579425

Publication URI: http://europepmc.org/abstract/MED/30579425

Type: Journal Article/Review

Volume: 139

Parent Publication: The Journal of investigative dermatology

Issue: 1

ISSN: 0022-202X